Strategies to Ensure Market Success of a Rare Disease Product Launch

Small patient populations, complex administration, high costs of therapies, and government policy interventions are just a few obstacles in rare disease.

EVERSANA’s Managing Director, Bill O’Bryon, and Senior Director, Diann Johnson, outline key insights to consider in your launch strategy:

1. Market dynamics impacting rare disease therapies
2. The entire rare community: patients, caregivers, providers & advocates
3. Payer landscape and engagement
4. Patient experience
5. Stakeholder relationships

Watch the Webinar: Strategies to Ensure Market Success of a Rare Disease Product Launch